LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,715 | -11.9% | 6,189 | -9.4% | 0.10% | -8.3% |
| Q2 2023 | $471,751 | +13.6% | 6,834 | -20.7% | 0.11% | +10.1% |
| Q1 2023 | $415,319 | +16.6% | 8,613 | +20.7% | 0.10% | +12.5% |
| Q4 2022 | $356,329 | +33.0% | 7,138 | +8.8% | 0.09% | +29.4% |
| Q3 2022 | $268,000 | -25.8% | 6,563 | 0.0% | 0.07% | -20.0% |
| Q2 2022 | $361,000 | +28.5% | 6,563 | -15.2% | 0.08% | +63.5% |
| Q1 2022 | $281,000 | +20.1% | 7,738 | +54.4% | 0.05% | +33.3% |
| Q4 2021 | $234,000 | – | 5,011 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |